FBLG FibroBiologics Inc

Price (delayed)

$1.02

Market cap

$5.31M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.93

Enterprise value

$6.31M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 0

We are a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple ...

Highlights
FibroBiologics's EPS has shrunk by 69% YoY but it has increased by 18% QoQ
The company's debt has shrunk by 65% YoY but it rose by 2.8% QoQ
The net income has dropped by 144% year-on-year
FBLG's quick ratio has dropped by 71% since the previous quarter and by 24% year-on-year

Key stats

What are the main financial stats of FBLG

FBLG stock price

How has the FibroBiologics stock price performed over time
Intraday
-4.67%
1 week
-9.73%
1 month
-26.09%
1 year
-94%
YTD
-77.33%
QTD
-22.73%

Financial performance

How have FibroBiologics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$17.19M
Net income
-$18.68M
Gross margin
N/A
Net margin
N/A
The net income has dropped by 144% year-on-year
FibroBiologics's operating income has decreased by 16% YoY and by 3.2% QoQ

Price vs fundamentals

How does FBLG's price correlate with its fundamentals

Growth

What is FibroBiologics's growth rate over time

Valuation

What is FibroBiologics stock price valuation
P/E
N/A
P/B
1.33
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
FibroBiologics's EPS has shrunk by 69% YoY but it has increased by 18% QoQ
The P/B is 97% lower than the last 4 quarters average of 53.6
The equity has shrunk by 58% QoQ but it rose by 11% YoY

Efficiency

How efficient is FibroBiologics business performance
FibroBiologics's ROE has decreased by 36% YoY but it has increased by 2.4% from the previous quarter
The ROIC has grown by 17% from the previous quarter
The ROA fell by 15% QoQ

Dividends

What is FBLG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FBLG.

Financial health

How did FibroBiologics financials performed over time
The total assets is 78% greater than the total liabilities
FBLG's quick ratio has dropped by 71% since the previous quarter and by 24% year-on-year
FibroBiologics's total liabilities has shrunk by 63% YoY and by 3.6% QoQ
The company's debt is 4.7% lower than its equity
The debt to equity has soared by 144% since the previous quarter but it has dropped by 69% year-on-year
The company's debt has shrunk by 65% YoY but it rose by 2.8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.